[PDF][PDF] Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with …

H von der Maase, L Sengelov, JT Roberts… - Journal of clinical …, 2005 - Citeseer
H von der Maase, L Sengelov, JT Roberts, S Ricci, L Dogliotti, T Oliver, MJ Moore…
Journal of clinical oncology, 2005Citeseer
Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With
Methotrexate, Vinblastine, Doxorubic Page 1 Long-Term Survival Results of a Randomized
Trial Comparing Gemcitabine Plus Cisplatin, With Methotrexate, Vinblastine, Doxorubicin,
Plus Cisplatin in Patients With Bladder Cancer Hans von der Maase, Lisa Sengelov, James T.
Roberts, Sergio Ricci, Luigi Dogliotti, T. Oliver, Malcolm J. Moore, Annamaria Zimmermann,
and Michael Arning A B S T R A C T Purpose To compare long-term survival in patients with …
Purpose
To compare long-term survival in patients with locally advanced or metastatic transitional cell carcinoma (TCC) of the urothelium treated with gemcitabine/cisplatin (GC) or methotrexate/vinblastine/doxorubicin/cisplatin (MVAC).
Citeseer